Skip to main content
Equibles
HAE logo

HAE · Haemonetics Corp · Webcasts, Transcripts & Audio

Track HAE — free

Use HAE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HAE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$119.04 -0.94 (-0.78%) Q1 2027 earnings call transcript
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.46B
Shares
45.50M
Volume · Oct 28 199.57K Avg daily vol (3M) 738.58K

Haemonetics Corp Webcasts

Earnings calls, investor updates, investor days and conferences for Haemonetics Corp (HAE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY27 · Q2
2026-11-05
Haemonetics Corp (HAE) Q2 2027 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY27 · Q1
2026-08-06
Haemonetics Corp (HAE) Q1 2027 Earnings Call Transcript
Confident tone Plasma franchise and Persona Plus adoption Board addition and governance refresh Hospital capital equipment environment / TEG
Revenue
$339.38M
▲ 5.6% YoY
Diluted EPS
$0.72
▲ 2.9% YoY
Gross margin
59.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q4
2026-05-07
Haemonetics Corp (HAE) Q4 2026 Earnings Call Transcript
Positive tone Plasma business momentum and guidance Margin expansion and cash flow Guidance assumptions and conservatism on volume
Revenue
$346.35M*
▲ 4.8% YoY
Gross margin
57.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q3
2026-02-05
Haemonetics Corp (HAE) Q3 2026 Earnings Call Transcript
Confident tone Plasma franchise momentum Interventional Technologies / vascular closure turnaround Margin expansion and free cash flow
Revenue
$338.97M
▼ 2.7% YoY
Diluted EPS
$0.95
▲ 28.4% YoY
Gross margin
59.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2025-11-06
Haemonetics Corp (HAE) Q2 2026 Earnings Call Transcript
Confident tone Plasma business strength FY26 guidance raise Interventional Technologies / Vascular Closure turnaround
Revenue
$327.31M
▼ 5.3% YoY
Diluted EPS
$0.81
▲ 22.7% YoY
Gross margin
59.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-08-07
Haemonetics Corp (HAE) Q1 2026 Earnings Call
Positive tone Plasma / NexSys Performance Blood Management Technologies / TEG Guidance Reaffirmation and Long-Range Plan
Revenue
$321.39M
▼ 4.4% YoY
Diluted EPS
$0.70
▼ 5.4% YoY
Gross margin
59.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-05-08
Haemonetics Corp (HAE) Q4 2025 Earnings Call Transcript
Positive tone Plasma and CSL Transition Hospital Business Growth Capital Allocation and Share Buyback
Revenue
$330.60M*
▼ 3.7% YoY
Gross margin
58.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-02-06
Haemonetics Corp (HAE) Q3 2025 Earnings Call Transcript
Confident tone Hospital segment growth Whole blood divestiture and portfolio rationalization Plasma business and CSL transition
Revenue
$348.54M
▲ 3.7% YoY
Diluted EPS
$0.74
▲ 21.3% YoY
Gross margin
55.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-11-07
Haemonetics Corp (HAE) Q2 2025 Earnings Call Transcript
Positive tone Plasma business and CSL transition Guidance and outlook Blood Management Technologies (TEG)
Revenue
$345.51M
▲ 8.6% YoY
Diluted EPS
$0.66
▲ 37.5% YoY
Gross margin
54.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-08-08
Haemonetics Corp (HAE) Q1 2025 Earnings Call Transcript
Positive tone Hospital / interventional technologies growth International expansion (Japan and Europe) Geopolitical and China headwinds
Revenue
$336.17M
▲ 8% YoY
Diluted EPS
$0.74
▼ 7.5% YoY
Gross margin
52.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-05-09
Haemonetics Corp (HAE) Q4 2024 Earnings Call Transcript
Confident tone FY2025 guidance and CSL headwind Plasma business and Express Plus rollout Acquisitions (OpSens and Attune)
Revenue
$343.29M*
▲ 12.8% YoY
Gross margin
51.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-02-08
Haemonetics Corp (HAE) Q3 2024 Earnings Call Transcript
Confident tone Hospital segment momentum Plasma franchise growth OpSens acquisition and integration
Revenue
$336.25M
▲ 10.1% YoY
Diluted EPS
$0.61
▼ 4.7% YoY
Gross margin
52.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2023-11-02
Haemonetics Corp (HAE) Q2 2024 Earnings Call Transcript
Revenue
$318.18M
▲ 7% YoY
Diluted EPS
$0.48
▼ 25% YoY
Gross margin
53.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-08-08
Haemonetics Corp (HAE) Q1 2024 Earnings Call Transcript
Revenue
$311.33M
▲ 19.1% YoY
Diluted EPS
$0.80
▲ 110.5% YoY
Gross margin
53.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-05-11
Haemonetics Corp (HAE) Q4 2023 Earnings Call Transcript
Revenue
$304.42M*
▲ 14.9% YoY
Gross margin
51.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-02-07
Haemonetics Corp (HAE) Q3 2023 Earnings Call Transcript
Revenue
$305.30M
▲ 17.5% YoY
Diluted EPS
$0.64
▲ 42.2% YoY
Gross margin
52.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-11-07
Haemonetics Corp (HAE) Q2 2023 Earnings Call Transcript
Revenue
$297.49M
▲ 24% YoY
Diluted EPS
$0.64
▲ 120.7% YoY
Gross margin
53.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-08-10
Haemonetics Corp (HAE) Q1 2023 Earnings Call Transcript
Revenue
$261.46M
▲ 14.4% YoY
Diluted EPS
$0.38
Gross margin
54.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-05-10
Haemonetics Corp (HAE) Q4 2022 Earnings Call Transcript
Revenue
$265.00M*
▲ 17.8% YoY
Gross margin
51.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-02-08
Haemonetics Corp (HAE) Q3 2022 Earnings Call Transcript
Revenue
$259.77M
▲ 8.1% YoY
Diluted EPS
$0.45
▼ 27.4% YoY
Gross margin
53.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2021-11-09
Haemonetics Corp (HAE) Q2 2022 Earnings Call Transcript
Revenue
$239.90M
▲ 14.5% YoY
Diluted EPS
$0.29
▼ 69.1% YoY
Gross margin
51.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-08-11
Haemonetics Corp (HAE) Q1 2022 Earnings Call Transcript
Revenue
$228.53M
▲ 16.8% YoY
Diluted EPS
$-0.09
▼ 142.9% YoY
Gross margin
47.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-05-13
Haemonetics Corp (HAE) Q4 2021 Earnings Call Transcript
Revenue
$225.03M
▼ 5.6% YoY
Diluted EPS
$-0.22
▼ 164.7% YoY
Gross margin
36.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-02-02
Haemonetics Corp (HAE) Q3 2021 Earnings Call Transcript
Revenue
$240.37M
▼ 7.2% YoY
Diluted EPS
$0.62
▲ 6.9% YoY
Gross margin
50.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2020-11-04
Haemonetics Corp (HAE) Q2 2021 Earnings Call Transcript
Revenue
$209.49M
▼ 17.1% YoY
Diluted EPS
$0.94
▲ 30.6% YoY
Gross margin
50.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-06-30
Date not confirmed
Haemonetics Corp (HAE) Q1 2021 Earnings Call Transcript
Revenue
$195.58M
▼ 18% YoY
Diluted EPS
$0.21
Gross margin
46.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-05-05
Haemonetics Corp (HAE) Q4 2020 Earnings Call Transcript
Revenue
$238.49M
▼ 4.3% YoY
Diluted EPS
$0.34
▼ 15% YoY
Gross margin
47.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-02-04
Haemonetics Corp (HAE) Q3 2020 Earnings Call Transcript
Revenue
$258.97M
▲ 4.7% YoY
Diluted EPS
$0.58
▲ 65.7% YoY
Gross margin
49.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2019-06-30
Date not confirmed
Haemonetics Corp (HAE) Q1 2020 Earnings Call Transcript
Revenue
$238.45M
▲ 4% YoY
Diluted EPS
$-0.17
Gross margin
48.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–29 of 29 webcasts
Key facts CIK 313143 CUSIP 405024100 13F (30d) 65 filings 60 filers Visit website Investor relations